Search
Conozca un ensayo clínico en Memorial Sloan Kettering que ofrece a las personas con cáncer de recto una nueva opción de tratamiento sin radiación. La investigación muestra que un régimen de quimioterapia conocido, usado solo, puede ser tan eficaz como la quimioterapia combinada con radiación antes de la cirugía. El nuevo método puede reducir los efectos secundarios de la radiación, como la pérdida de fertilidad y los problemas en la función de la vejiga y la función sexual.
Two outstanding graduate students from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences (GSK) have been awarded federal funding to pursue promising cancer research.
Almost everyone gets medical information online, but it can be hard to know what's true. In this story, MSK provides tips for evaluating online content.
The National Academy of Medicine (NAM) has named Hedvig Hricak, MD, PhD, Chair of the Department of Radiology, a recipient of the David Rall Medal. The medal is given annually to a NAM member who has demonstrated outstanding leadership. Dr. Hricak received the award at the 2018 NAM Annual Meeting on Monday, October 15, 2018, in Washington, D.C.
Luis Alberto Diaz, Jr. has dedicated his life’s work to addressing some of the most pressing challenges in cancer research — driven by one clear aim.
Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Larry Norton, MD, has been elected to the American Academy of the Arts & Sciences, and Michel Sadelain, MD, PhD, has been named the recipient of the Outstanding Achievement Award from the American Society of Gene and Cell Therapy.
A multi-institutional study led by Memorial Sloan Kettering Cancer Center (MSKCC) shows that patients whose colorectal cancer has spread to the liver and who received chemotherapy directly to the liver through a pump in the abdomen (an approach called Hepatic Arterial Infusion or HAI) fare better than those who received systemic (intravenously administered) chemotherapy.
Almost three-fourths of pediatric cancer survivors will have a chronic health problem within 30 years after the cancer diagnosis, with 40 percent experiencing a serious, life-threatening, disabling, or fatal condition, according to investigators from Memorial Sloan Kettering Cancer Center (MSKCC), St. Jude Children's Research Hospital, and other institutions.
A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients.